Preneoplastic lesions in gallbladder cancer

Journal of Surgical Oncology

Volumn 93, Issue 8, 2006, Pages 615-623

  Roa, Iván ^a,b,c   De Aretxabala, Xabier ^b   Araya, Juan C ^a   Roa, Juan ^a  

^a UNIVERSIDAD DE LA FRONTERA   (Chile)

^b UNIVERSIDAD DEL DESARROLLO   (Chile)

^c NONE   (Chile)

Author keywords

Adenoma; Cancer; Dysplasia; Gallbladder; Preneoplastic

Indexed keywords

ADENOMA; CANCER INCIDENCE; CANCER INVASION; CARCINOGENESIS; CARCINOMA IN SITU; CHOLECYSTECTOMY; CHOLELITHIASIS; CLINICAL PATHWAY; CONFERENCE PAPER; DYSPLASIA; GALLBLADDER CANCER; HUMAN; MALIGNANT TRANSFORMATION; METAPLASIA; PRECANCER; PRIORITY JOURNAL;

EID: 33744951007     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.20527     Document Type: Conference Paper

References (86)

1. Misra S, Chaturvedi A, Misru NC, et al.: Carcinoma of the gallbladder. Lancet Oncol 2003;4:167-176.
2. Kodama K, Nakadaira H, Endoh K, et al.: Geographic clustering patterns in mortality from biliary tract cancer in Japan. Jpn J Cancer Res 1998;89:6-11.
3. Paltoo DN, Chu KC: Patterns in cancer incidence among American Indians/Alaska States, 1992-1999. Public Health Rep 2004;119:443-451.
4. Nandakumar A, Gupta PC, Gangadharan P, et al.: Geographic pathology revisited: Development of an atlas of cancer in India. Int J Cancer 2005;116:740-754.
5. Kapoor VK, McMichael AJ. Gallbladder cancer: An 'Indian' disease. Natl Med J India 2003;16:209-213.
6. Lazcano-Ponce EC, Miquel JF, Munoz N, et al.: Epidemiology and molecular pathology of gallbladder cancer. CA Cancer J Clin 2001;51:349-364.
7. Nervi F, Duarte I, Gomez G, et al.: Frequency of gallbladder cancer in Chile, a high-risk area. Int J Cancer 1988;41:657-660.
8. Pandey M: Risk factors for gallbladder cancer: A reappraisal. Eur J Cancer Prev 2003;12:15-24.
9. Medina E, Kaempffer AM: Cancer mortality in Chile: Epidemiological considerations. Rev Med Chil 2001;129:1195-1202.
10. Serra I: Has gallbladder cancer mortality decrease in Chile? Rev Med Chil 2001;129:1079-1084.
11. Wistuba II, Gazdar AF: Gallbladder cancer: Lessons from a rare tumour. Nat Rev Cancer 2004;4:695-706.
12. Pitt HA: Gallbladder cancer: What is an aggressive approach? Ann Surg 2005;241:395-396.
13. de Aretxabala X, Roa I, Burgos L: Gallbladder cancer, management of early tumors. Hepatogastroenterology 1999;46:1547-1551.
14. Todoroki T, Kawamoto T, Takahashi H, et al.: Treatment of gallbladder cancer by radical resection. Br J Surg 1999;86:622-627.
15. Todoroki T: Chemotherapy for gallbladder carcinoma-a surgeon's perspective. Hepatogastroenterology 2000;47:948-955.
16. Taner CB, Nagorney DM, Donohue JH: Surgical treatment of gallbladder cancer. J Gastrointest Surg 2004;8:83-89; discussion.
17. Roa JC, Roa I, Correa P, et al.: Microsatellite instability in preneoplastic and neoplastic gallbladder. J Gastroenterol 2005; 40:79-86.
18. Wistuba II, Maitra A, Carrasco R, et al.: High resolution chromosome 3p, 8p, 9q and 22q allelotyping analysis in the pathogenesis of gallbladder carcinoma. Br J Cancer 2002; 87:432-440.
19. Rashid A: Cellular and molecular biology of biliary tract cancers. Surg Oncol Clin N Am 2002;11:995-1009.
20. Wistuba II, Albores-Saavedra J: Genetic abnormalities involved in the pathogenesis of gallbladder carcinoma. J Hepatobiliary Pancreat Surg 1999;6:237-244.
21. Lowenfels AB, Maisonneuve P, Boyle P, et al.: Epidemiology of gallbladder cancer. Hepatogastroenterology 1999;46:1529-1532.
22. Chow WH, Johansen C, Gridley G, et al.: Gallstones, cholecystectomy and risk of cancers of the liver, biliary tract and pancreas. Br J Cancer 1999;79:640-644.
23. Lowenfels AB, Walker AM, Althaus DP, et al.: Gallstone growth, size, and risk of gallbladder cancer: An interracial study. Int J Epidemiol 1989;18:50-54.
24. Roa I, de Aretxabala X, Morgan R, et al.: Clinicopathological features of gallbladder polyps and adenomas. Rev Med Chil 2004;132:673-679.
25. Kozuka S, Tsubone N, Yasui A, et al.: Relation of adenoma to carcinoma in the gallbladder. Cancer 1982;50:2226-2234.
26. Jung YS, Lee KJ, Kim H, et al.: Risk factor for extrahepatic bile duct cancer in patients with pancreaticobiliary ductal union. Hepatogastroenterology 2004;51:946-949.
27. Matsumoto Y, Fujii H, Itakura J, et al.: Recent advances in pancreaticobiliary maljunction. J Hepatobiliary Pancreat Surg 2002;9:45-54.
28. Serra I, Calvo A, Maturana M, et al.: Changing trends of gallbladder cancer in Chile, a high-risk area. Int J Cancer 1990;45: 376-377.
29. Chianale J, del Pino G, Nervi F: Increasing gall-bladder cancer mortality rate during the last decade in Chile, a high-risk area. Int J Cancer 1990;46:1131-1133.
30. Pandey M, Shukla VK: Lifestyle, parity, menstrual and reproductive factors and risk of gallbladder cancer. Eur J Cancer Prev 2003;12:269-272.
31. Donohue JH: Present status of the diagnosis and treatment of gallbladder carcinoma. J Hepatobiliary Pancreat Surg 2001;8: 530-534.
32. Shaffer EA: Epidemiology and risk factors for gallstone disease: Has the changed in the 21st century? Curr Gastroenterol Rep 2005;7:132-140.
33. Batra Y, Pal S, Dutta U, et al.: Gallbladder cancer in India: A dismal picture. J Gastroenterol Hepatol 2005;20:309-314.
34. Albores-Saavedra J, Alcantra-Vazquez A, Cruz-Ortiz H, et al.: The precursor lesions of invasive gallbladder carcinoma. Hyperplasia, atypical hyperplasia and carcinoma in situ. Cancer 1980;45:919-927.
35. Albores-Saavedra J, Vardaman CJ, Vuitch F: Non-neoplastic polypoid lesions and adenomas of the gallbladder. Pathol Annu 1993;28:145-177.
36. Duarte I, Llanos O, Domke H, et al.: Metaplasia and precursor lesions of gallbladder carcinoma. Frequency, distribution, and probability of detection in routine histologic samples. Cancer 1993;72:1878-1884.
37. Aldridge MC, Bismuth H: Gallbladder cancer: The polyp-cancer sequence. Br J Surg 1990;77:363-364.
38. Wistuba II, Miquel JF, Gazdar AF, et al.: Gallbladder adenomas have molecular abnormalities present in gallbladder carcinomas. Hum Pathol 1999;30:21-25.
39. Roa I, Araya JC, Villaseca M, et al.: Preneoplastic lesions and gallbladder cancer. An estimate of the period required for progression. Gastroenterology 1996;111:232-236.
40. Laitio M: Histogenesis of epithelial neoplasms of human gallbladder I. Dysplasia. Pathol Res Pract 1983;178:51-56.
41. Wistuba I, Sugio K, Hung J, et al.: Allele-specific mutations involved in the pathogenesis of endemic gallbladder carcinoma in Chile. Cancer Res 1995;55:2511-2515.
42. Mukhopadhyay S, Landas SK: Putative precursors of gallbladder dysplasia: A review of 400 routinely resected specimens. Arch Pathol Lab Med 2005;129:386-390.
43. Roa I, Araya JC, Wistuba I, et al.: Gallbladder cancer: Anatomic and anatomo-pathologic considerations. Rev Med Chil 1990;118: 572-579.
44. Roa I, Araya JC, Villaseca M, et al.: Gallbladder cancer in a high risk area: Morphological features and spread patterns. Hepatogastroenterology 1999;46:1540-1546.
45. Gallbladder. In: American Joint Committee on Cancer: AJCC Cancer Staging Manual. 5th edition. Philadelphia, Pa: Lippincott-Raven Publishers 1997; pp 103-108.
46. Albores-Saavedra J, Henson DE, Sobin LH: The WHO histological classification of tumors of the gallbladder and extrahepatic bile ducts. A commentary on the second edition. Cancer 1992;70: 410-414.
47. Alonso de Ruiz P, Albores-Saavedra J, Henson DE, et al.: Cytopathology of precursor lesions of invasive carcinoma of the gallbladder: A study of bile aspirated from surgically excised gallbladders. Acta Cytol 1982;26:144-152.
48. Yamamoto M, Nakajo S, Tahara E: Histological classification of epithelial polypoid lesions of the gallbladder. Acta Pathol Jpn 1988;38:181-192.
49. Laitio M: Histogenesis of epithelial neoplasms of human gallbladder II. Classification of carcinoma on the basis of morphological features. Pathol Res Pract 1983;178:57-66.
50. Dowling GP, Kelly JK: The histogenesis of adenocarcinoma of the gallbladder. Cancer 1986;58:1702-1708.
51. Yamagiwa H: Dysplasia of gallbladder. Its pathological significance. Acta Pathol Jpn 1987;37:747-754.
52. Roa I, Araya JC, Wistuba I, et al.: Epithelial lesions associated with gallbladder carcinoma. A methodical study of 32 cases. Rev Med Chil 1993;121:21-29.
53. Yamagiwa H: Mucosal dysplasia of gallbladder: Isolated and adjacent lesions to carcinoma. Jpn J Cancer Res 1989;80;238-243.
54. Roa I, de Aretxubala X, Araya JC, et al.: Incipient gallbladder carcinoma. Clinical and pathological study and prognosis in 196 cases. Rev Med Chil 2001;129:1113-1120.
55. Ojeda VJ, Shilkin KB, Walters MN: Premalignant epithelial lesions of the gall bladder. A prospective study of 120 cholecystectomy specimens. Pathology 1985;17:451-454.
56. Tsuchiya Y: Early carcinoma of the gallbladder: Macroscopic features and US findings. Radiology 1991;179:171-175.
57. Laitio M: Early carcinoma of the gallbladder. Beitr Pathol 1976;158:159-172.
58. Wagholikar GD, Behari A, Krishnani N, et al.: Early gallbladder cancer. J Am Coll Surg 2002;194:137-141.
59. Tazuma S, Kajiyama G: Carcinogenesis of malignant lesions of the gall bladder. The impact of chronic inflammation and gallstones. Langenbecks Arch Surg 2001;386:224-229.
60. Kozuka S, Kurashina M, Tsubone M, et al.: Significance of intestinal metaplasia for the evolution of cancer in the biliary tract. Cancer 1984;54:2277-2285.
61. Yamagiwa H, Tomiyama H: Intestinal metaplasia-dysplasia-carcinoma sequence of the gallbladder. Acta Pathol Jpn 1986; 36:989-997.
62. Albores-Saavedra J, Nadjo M, Henson D, et al.; Intestinal metaplasia of the gallblader: A morphologic and immunocytochemical study. Hum Pathol 1986;17:614-620.
63. Kushima R, Lohe B, Borchard F: Differentiation towards gastric foveolar, mucopeptic and intestinal goblet cells in gallbladder adenocarcinomas. Histopathology 1996;29:443-448.
64. Roa I, Araya JC, Shiraishi T, et al.: Immunohistochemical demonstration of pepsinogens I and II in the gallbladder. Rev Med Chil 1992;120:1351-1358.
65. Tatematsu M, Ichinose M, Miki K, et al.: Gastric phenotypic expression in human gallbladder cancers revealed by pepsinogen immunohistochemistry and mucin histochemistry. Virchows Arch A Pathol Anal Histopathol 1988;413:25-32.
66. Yamamoto M, Nakajo S, Tahara E: Dysplasia of the gallbladder. Its histogenesis and correlation to gallbladder adenocarcinoma. Pathol Res Pract 1989;185:454-460.
67. Roa JC, Roa I, Correa P, et al.: Microsatellite instability in preneoplastic and neoplastic lesions of the gallbladder. J Gastroenterol 2005;40:79-86.
68. Wistuba II, Albores-Saavedra J: Genetic abnormalities involved in the pathogenesis of gallbladder carcinoma. J Hepatobiliary Pancreat Surg 1999;6:237-244.
69. Kapoor VK, Pradeep R, Haribhakti SP, et al.: Early carcinoma of the gallbladder: An elusive disease. J Surg Oncol 1996;62:284-287.
70. Kraas E, Frauenschuh D, Farke S: Intraoperative suspicion of gallbladder carcinoma in laparoscopic surgery: What to do? Dig Surg 2002;19:489-493.
71. Sugiyama M, Xie XY, Atomi Y, et al.: Differential diagnosis of small polypoid lesions of the gallbladder: The value of endoscopic ultrasonography. Ann Surg 1999;229:498-504.
72. Sun XJ, Shi JS, Han Y, et al.: Diagnosis and treatment of polypoid lesions of the gallbladder: 194 cases. Hepatobiliary Pancreat Dis Int 2004;3:591-594.
73. Terzi C, Sokmen S, Seckin S, et al.: Polypoid lesions of the gallbladder; Report of 100 cases with special reference to operative indications. Surgery 2000;127:622-627.
74. Mainprize KS, Could SW, Gilbert JM: Surgical management of polypoid lesions of the gallbladder. Br J Surg 2000;87:414-417.
75. Collett JA, Allan RB, Chisholm RJ, et al.: Gallbladder polyps: Prospective study. J Ultrasound Med 1998;17:207-211.
76. Nakajo S, Yamamoto M, Tahara E: Morphometrical analysis of gall-bladder adenoma and adenocarcinoma with reference to histogenesis and adenoma-carcinoma sequence. Virchows Arch A Pathol Anat Histopathol 1990;417:49-56.
77. Shinkai H, Kimura W, Muto T: Surgical indications for small polypoid lesions of the gallbladder. Am J Surg 1998;175:114-117.
78. Chang HJ, Jee CD, Kim WH: Mutation and altered expression of beta-catenin during gallbladder carcinogencsis. Am J Surg Pathol 2002;26:758-766.
79. Wistuba II, Miquel JF, Gazdar AF, et al.: Gallbladder adenomas have molecular abnormalities different from those present in gallbladder carcinomas. Hum Pathol 1999;30:21-25.
80. Watanabe H, Date K, Itoi T, et al.: Histological and genetic changes in malignant transformation of gallbladder adenoma. Ann Oncol 1999;10:136-139.
81. Yanagisawa N, Mikami T, Saegusa M, et al.: More frequent beta-catenin exon 3 mutations in gallbladder adenomas than in carcinomas indicate different lineages. Cancer Res 2001;61:19-22.
82. Roa I, Araya JC, Wistuba I, et al.: In situ and invasive cancer of the gallbladder: Nucleolar organizer regions. Rev Med Chil 1990;118:369-372.
83. Albores-Saavedra J, Henson DE, Sobin LH: The WHO histological classification of tumors of the gallbladder and extrahepatic bile ducts. A commentary on the second edition. Cancer 1992;70: 410-414.
84. Billo P, Marchegiani C, Capella C, et al.: Expression of p53 in gallbladder carcinoma and in dysplastic and metaplastic lesions of the surrounding mucosa. Pathologica 2000;92:249-256.
85. Wistuba II, Sugio K, Hung J, et al.: Allele-specific mutations involved in the pathogenesis of endemic gallbladder carcinoma in Chile. Cancer Res 1995;55;2511-2515.
86. Roa JC, Vo Q, Araya JC, et al.: Inactivation of CDKN2A gene (p16) in gallbladder carcinoma. Rev Med Chil 2004;132:1369-1376.